In human acute myeloid leukemia, activation of RANKL expressed by tumor cells leads to a dual inhibition of NK cells, through the secretion of immunomodulatory factors directly inhibiting NK cells and the upregulation of RANK expression by NK cells. This evidence concerns the gene TNFSF11 and acute myeloid leukemia.